NM_004483.5:c.505A>C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_004483.5(GCSH):c.505A>C(p.Lys169Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000115 in 1,304,794 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004483.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GCSH | ENST00000315467.9 | c.505A>C | p.Lys169Gln | missense_variant | Exon 5 of 5 | 1 | NM_004483.5 | ENSP00000319531.3 | ||
ENSG00000284512 | ENST00000640345.1 | c.424+1580A>C | intron_variant | Intron 4 of 5 | 5 | ENSP00000492798.1 | ||||
ENSG00000260643 | ENST00000564536.2 | c.424+1580A>C | intron_variant | Intron 4 of 5 | 5 | ENSP00000491651.1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151430Hom.: 0 Cov.: 27
GnomAD4 exome AF: 0.0000104 AC: 12AN: 1153364Hom.: 0 Cov.: 16 AF XY: 0.00000340 AC XY: 2AN XY: 588378
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151430Hom.: 0 Cov.: 27 AF XY: 0.0000135 AC XY: 1AN XY: 73924
ClinVar
Submissions by phenotype
Glycine encephalopathy Uncertain:1
This sequence change replaces lysine with glutamine at codon 169 of the GCSH protein (p.Lys169Gln). The lysine residue is moderately conserved and there is a small physicochemical difference between lysine and glutamine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with GCSH-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at